Moesgaard Nielsen V, Vinther B, Illum P
Rhinology. 1983 Sep;21(3):257-63.
The clinical effect and the side effects of a new steroid, Fluocortin butylester (FCB) in the topical treatment of hay fever was studied in a double-blind trial. The drug was administered by inhalation of a fine powder through a special inhalator (Rhinolator). The material comprised 31 patients, and the treatment period was three weeks. There was a highly significant difference in favour of FCB compared with placebo as regards the nasal symptoms blockage and discharge. Side effects were few and mild.
在一项双盲试验中，研究了一种新型类固醇氟可丁酯（FCB）局部治疗花粉热的临床疗效和副作用。该药物通过一种特殊的吸入器（鼻用吸入器）吸入细粉给药。研究对象包括31名患者，治疗期为三周。在鼻塞和流涕等鼻部症状方面，与安慰剂相比，FCB有非常显著的优势。副作用少且轻微。
